These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 30262653

  • 1. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella.
    Micoli F, Rondini S, Alfini R, Lanzilao L, Necchi F, Negrea A, Rossi O, Brandt C, Clare S, Mastroeni P, Rappuoli R, Saul A, MacLennan CA.
    Proc Natl Acad Sci U S A; 2018 Oct 09; 115(41):10428-10433. PubMed ID: 30262653
    [Abstract] [Full Text] [Related]

  • 2. Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella.
    De Benedetto G, Alfini R, Cescutti P, Caboni M, Lanzilao L, Necchi F, Saul A, MacLennan CA, Rondini S, Micoli F.
    Vaccine; 2017 Jan 11; 35(3):419-426. PubMed ID: 27998639
    [Abstract] [Full Text] [Related]

  • 3. Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.
    Lanzilao L, Stefanetti G, Saul A, MacLennan CA, Micoli F, Rondini S.
    PLoS One; 2015 Jan 11; 10(10):e0139847. PubMed ID: 26445460
    [Abstract] [Full Text] [Related]

  • 4. IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal Salmonella Develop at Discordant Rates.
    Schager AE, Dominguez-Medina CC, Necchi F, Micoli F, Goh YS, Goodall M, Flores-Langarica A, Bobat S, Cook CNL, Arcuri M, Marini A, King LDW, Morris FC, Anderson G, Toellner KM, Henderson IR, López-Macías C, MacLennan CA, Cunningham AF.
    mBio; 2018 Mar 06; 9(2):. PubMed ID: 29511082
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
    Rondini S, Micoli F, Lanzilao L, Gavini M, Alfini R, Brandt C, Clare S, Mastroeni P, Saul A, MacLennan CA.
    Infect Immun; 2015 Mar 06; 83(3):996-1007. PubMed ID: 25547792
    [Abstract] [Full Text] [Related]

  • 7. Relationship between antibody susceptibility and lipopolysaccharide O-antigen characteristics of invasive and gastrointestinal nontyphoidal Salmonellae isolates from Kenya.
    Onsare RS, Micoli F, Lanzilao L, Alfini R, Okoro CK, Muigai AW, Revathi G, Saul A, Kariuki S, MacLennan CA, Rondini S.
    PLoS Negl Trop Dis; 2015 Mar 06; 9(3):e0003573. PubMed ID: 25739091
    [Abstract] [Full Text] [Related]

  • 8. Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.
    Simon R, Wang JY, Boyd MA, Tulapurkar ME, Ramachandran G, Tennant SM, Pasetti M, Galen JE, Levine MM.
    PLoS One; 2013 Mar 06; 8(5):e64680. PubMed ID: 23741368
    [Abstract] [Full Text] [Related]

  • 9. Nontyphoidal salmonella disease: Current status of vaccine research and development.
    Tennant SM, MacLennan CA, Simon R, Martin LB, Khan MI.
    Vaccine; 2016 Jun 03; 34(26):2907-2910. PubMed ID: 27032517
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal Antibodies of a Diverse Isotype Induced by an O-Antigen Glycoconjugate Vaccine Mediate In Vitro and In Vivo Killing of African Invasive Nontyphoidal Salmonella.
    Goh YS, Clare S, Micoli F, Saul A, Mastroeni P, MacLennan CA.
    Infect Immun; 2015 Sep 03; 83(9):3722-31. PubMed ID: 26169269
    [Abstract] [Full Text] [Related]

  • 11. Effect of O-Antigen Chain Length Regulation on the Immunogenicity of Shigella and Salmonella Generalized Modules for Membrane Antigens (GMMA).
    Gasperini G, Raso MM, Arato V, Aruta MG, Cescutti P, Necchi F, Micoli F.
    Int J Mol Sci; 2021 Jan 28; 22(3):. PubMed ID: 33525644
    [Abstract] [Full Text] [Related]

  • 12. Invasive African Salmonella Typhimurium induces bactericidal antibodies against O-antigens.
    Rondini S, Lanzilao L, Necchi F, O'Shaughnessy CM, Micoli F, Saul A, MacLennan CA.
    Microb Pathog; 2013 Oct 28; 63():19-23. PubMed ID: 23756206
    [Abstract] [Full Text] [Related]

  • 13. Impact of conjugation chemistry on the immunogenicity of S. Typhimurium conjugate vaccines.
    Stefanetti G, Rondini S, Lanzilao L, Saul A, MacLennan CA, Micoli F.
    Vaccine; 2014 Oct 21; 32(46):6122-9. PubMed ID: 25192974
    [Abstract] [Full Text] [Related]

  • 14. Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis.
    Rossi O, Caboni M, Negrea A, Necchi F, Alfini R, Micoli F, Saul A, MacLennan CA, Rondini S, Gerke C.
    Clin Vaccine Immunol; 2016 Apr 21; 23(4):304-14. PubMed ID: 26865597
    [Abstract] [Full Text] [Related]

  • 15. Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort.
    Hanumunthadu B, Kanji N, Owino N, Ferreira Da Silva C, Robinson H, White R, Ferruzzi P, Nakakana U, Canals R, Pollard AJ, Ramasamy M, Vacc-iNTS Consortium.
    BMJ Open; 2023 Nov 14; 13(11):e072938. PubMed ID: 37963701
    [Abstract] [Full Text] [Related]

  • 16. GMMA and Glycoconjugate Approaches Compared in Mice for the Development of a Vaccine against Shigella flexneri Serotype 6.
    Raso MM, Gasperini G, Alfini R, Schiavo F, Aruta MG, Carducci M, Forgione MC, Martini S, Cescutti P, Necchi F, Micoli F.
    Vaccines (Basel); 2020 Apr 03; 8(2):. PubMed ID: 32260067
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice.
    Baliban SM, Curtis B, Toema D, Tennant SM, Levine MM, Pasetti MF, Simon R.
    PLoS Negl Trop Dis; 2018 May 03; 12(5):e0006522. PubMed ID: 29791435
    [Abstract] [Full Text] [Related]

  • 18. Maternal Antibodies Elicited by Immunization With an O- Polysaccharide Glycoconjugate Vaccine Protect Infant Mice Against Lethal Salmonella Typhimurium Infection.
    Baliban SM, Curtis B, Amin MN, Levine MM, Pasetti MF, Simon R.
    Front Immunol; 2019 May 03; 10():2124. PubMed ID: 31555302
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity and protective efficacy against Salmonella C2-C3 infection in mice immunized with a glycoconjugate of S. Newport Core-O polysaccharide linked to the homologous serovar FliC protein.
    Schuster O, Sears KT, Ramachandran G, Fuche FJ, Curtis B, Tennant SM, Simon R.
    Hum Vaccin Immunother; 2019 May 03; 15(6):1436-1444. PubMed ID: 29873578
    [Abstract] [Full Text] [Related]

  • 20. Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal Models.
    Micoli F, Alfini R, Di Benedetto R, Necchi F, Schiavo F, Mancini F, Carducci M, Oldrini D, Pitirollo O, Gasperini G, Balocchi C, Bechi N, Brunelli B, Piccioli D, Adamo R.
    Front Immunol; 2021 May 03; 12():719315. PubMed ID: 34594333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.